Company: NDRA
Filing Date: 2025-03-31
Form Type: 10-K
Source: 0001654954-25-003612
Chunk: 428

Company: ENDRA Life Sciences Inc.
Filing Date: 2025-03-31
Form: 10-K
Item: Item 1C
Chunk 428
---
hibitFiling Date3.1Fourth Amended and Restated Certificate of Incorporation of the Company, as amended [Restated for SEC filing purposes only]x   3.2Amended and Restated Bylaws of the Company S-13.412/06/164.1Specimen Certificate representing shares of common stock of the Company S-14.111/21/164.2Certificate of Designations of Series A Convertible Preferred Stock 8-K4.112/11/194.3Form of Warrant issued in December 2019 Series A Convertible Preferred Stock Offering 8-K4.212/11/194.4Certificate of Designations of Series B Convertible Preferred Stock 8-K4.112/26/194.5Form of Warrant issued in December 2019 Series B Convertible Preferred Stock Offering 8-K4.212/26/194.6Certificate of Designations of Series C Preferred Stock 8-K3.109/27/224.7Form of Warrant issued in April 2023 Underwritten Public Offering S-14.203/30/234.8Form of Underwriter’s Warrant issued in April 2023 Underwritten Public Offering S-1/A4.304/18/234.9Form of Warrant Agency Agreement S-14.403/30/234.10Form of Placement Agent Warrant S-14.505/10/244.11Form of Series A Warrant S-14.205/31/244.12Form of Series B Warrant  S-14.305/31/244.13Form of Pre-Funded Warrant S-14.405/10/244.14Amendment to Series A Warrant 10-Q3.808/14/244.15Amendment to Series B Warrant 10-Q3.908/14/244.16Description of Securities 10-K4.1203/30/2210.1ENDRA Life Sciences Inc. 2016 Omnibus Incentive Plan* S-110.412/06/1610.2First Amendment to ENDRA Life Sciences Inc. 2016 Omnibus Incentive Plan* DEF 14AAppx. A05/10/1810.3Form of Stock Option Award under 2016 Omnibus Incentive Plan* S-110.512/06/16

 66Table of Contents

10.